Attached files
file | filename |
---|---|
10-K/A - 10-K/A - INTERCEPT PHARMACEUTICALS, INC. | v408719_10ka.htm |
EX-3.1 - EXHIBIT 3.1 - INTERCEPT PHARMACEUTICALS, INC. | v408719_exh3x1.htm |
EX-31.4 - EXHIBIT 31.4 - INTERCEPT PHARMACEUTICALS, INC. | v408719_exh31x4.htm |
Exhibit 31.3
CERTIFICATIONS UNDER SECTION 302
I, Mark Pruzanski, M.D., certify that:
1. | I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of Intercept Pharmaceuticals, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 30, 2015
/s/ Mark Pruzanski
Mark Pruzanski, M.D.
President and Chief Executive Officer
(Principal Executive Officer)